Furthermore, human tissue analysis revealed lower nuclear NRF2 expression in IPMN compared with PanIN and PDA, suggesting distinct regulatory mechanisms across pancreatic precursor lesions. This evidence concerns the gene NFE2L2 and pancreatic intraductal papillary-mucinous neoplasm.